Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Baoji
- Development stage
- Phase 4
- Lead developer
- West China Hospital of Sichuan University
- Administration
- Oral
01
Overview
Baoji is a Traditional Chinese Medicine (TCM) formulation, commonly available as pills (Baoji Wan) or tablets, used primarily for the treatment of gastrointestinal disorders and the prevention of motion sickness. In the context of TCM, it is indicated for "turbid dampness stagnation syndrome," which manifests as nausea, vomiting, abdominal pain, and diarrhea. The formulation typically contains a complex blend of herbal ingredients, including Poria, Radix Aucklandiae, and Herba Pogostemonis, which work synergistically to regulate the digestive system and alleviate symptoms of dampness. A multicenter clinical trial sponsored by West China Hospital of Sichuan University has investigated its efficacy and safety specifically for motion sickness.
- Brand names
- Baoji TabletsPo Chai Pills
- Other names
- Baoji WanBao Ji Wan
Beyond the preview
Go deeper on Baoji.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Explore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Trace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Explore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Compare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Connect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Baoji.